BlackRock Inc. Makes New Investment in Akebia Therapeutics, Inc. $AKBA
BlackRock Inc. acquired a new stake in shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 19,986,374 shares of the biopharmaceutical company’s stock, valued at approximately $22,784,000. BlackRock Inc. owned approximately 0.07% of Akebia Therapeutics […]
3 Sep 07:48 · The Markets Daily